NasdaqGM - Nasdaq Real Time Price USD
Apogee Therapeutics, Inc. (APGE)
36.33
-0.31
(-0.85%)
At close: June 2 at 4:00:02 PM EDT
36.33
0.00
(0.00%)
After hours: June 2 at 4:04:07 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
-188,015
-171,174
-74,761
-16,427
Investing Cash Flow
-235,737
-300,462
-273,910
0
Financing Cash Flow
45,211
495,109
315,391
168,317
End Cash Position
107,210
142,083
118,610
151,890
Capital Expenditure
-5,118
-1,152
-167
--
Issuance of Capital Stock
42,987
493,483
315,391
168,317
Free Cash Flow
-193,133
-172,326
-74,928
-16,427
12/31/2022 - 7/14/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACLX Arcellx, Inc.
61.93
-0.21%
SYRE Spyre Therapeutics, Inc.
15.40
+0.79%
RYTM Rhythm Pharmaceuticals, Inc.
63.66
+3.80%
NUVL Nuvalent, Inc.
77.18
+3.44%
RVMD Revolution Medicines, Inc.
40.65
+3.17%
BPMC Blueprint Medicines Corporation
127.79
+26.09%
CNTA Centessa Pharmaceuticals plc
13.41
-0.74%
VERA Vera Therapeutics, Inc.
31.74
+67.49%
CGON CG Oncology, Inc.
26.59
+3.79%
PHVS Pharvaris N.V.
16.49
-0.66%